Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
September 5, 2025Acta Neurologica BelgicaOpen Access

The current status of Charcot-Marie-Tooth disease type 1 A treatment

View Full Paper
Ask AI
Bookmark
Share

Authors

HQHuanhuan QiWuhan Polytechnic UniversityXWXin WangKunming University of Science and TechnologyBWBing WuAnhui University

Discussion

Loading...

Member takes

Overview

Preclinical studies highlight potential therapies for CMT1A, suggesting gene editing and PXT3003 may improve outcomes.

Key Points

  • PXT3003 demonstrates phase III efficacy, significantly relieving symptoms of charcot-marie-tooth disease type 1A and reducing neuropathy.
  • Recent advances in gene editing show promise but raise concerns about off-target effects in charcot-marie-tooth disease type 1A treatment.
  • Multidisciplinary supportive care remains the cornerstone of managing charcot-marie-tooth disease type 1A among patients with progressive muscle atrophy.
  • Induced pluripotent stem cell technology opens doors for innovative stem cell therapies in the treatment of charcot-marie-tooth disease type 1A.

Cite This Study

Qi et al. (2025) studied this question.

synapsesocial.com/papers/68bb3a3d2b87ece8dc95508dhttps://doi.org/10.1007/s13760-025-02881-1
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Charcot‐Marie‐Tooth Disease: An Overview of Genotypes, Phenotypes, and Clinical Management Strategies2014 · 53 citations
  2. 2Generation of one induced pluripotent stem cell line JUCGRMi004-A from a Charcot-Marie-Tooth disease type 1A (CMT1A) patient with PMP22 duplication2024 · 1 citations
  3. 3Hereditary neuropathies caused by mutations in the gene encoding peripheral myelin protein 222025
  4. 4Peripheral Myelin Protein-22 and Its Prominence in Charcot-Marie-Tooth Disease2026 · 1 citations
  5. 5Advances and challenges in modeling Charcot-Marie-Tooth type 2A using iPSC-derived models2025